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Background: Neck pain caused by cervical spondylosis has become a common health problem worldwide among
>40-year-old adults. Acupuncture intervention is one of the most popular treatment measures for this disorder.
However, evidence for its efficacy in relieving neck pain and recovering neck physiological function has not been
established in randomized, placebo-controlled trials. The primary aim of this trial is to assess the efficacy and safety
of active acupuncture compared with sham acupuncture intervention for neck pain caused by cervical spondylosis.
Methods/Design: We will conduct a randomized, double-blind, parallel-group, placebo-controlled trial comparing
active acupuncture with placebo (sham acupuncture). A total of 456 patients with neck pain caused by cervical
spondylosis who meet the eligibility criteria from outpatient clinics of the Second People’s Hospital of Fujian
Province and the Affiliated Rehabilitation Hospital, Fujian University of Traditional Chinese Medicine will be recruited
and randomized into an active acupuncture or sham acupuncture group. The participants will undergo treatment
sessions with either active or sham acupuncture intervention five times a week for 2 weeks. Evaluation by blinded
assessors at baseline and at intervention for 1 and 2 weeks will include demographic characteristics, validated
questionnaires (Northwick Park Neck Pain Questionnaire (NPQ) scale, Short-Form 36 (SF-36) scale, and McGill pain
scale), examination of neck physiological function, and adverse events. All included patients will be followed up
and investigated for relapse of neck pain at 4, 8, and 12 weeks after intervention.
Discussion: This paper describes the rationale and design of a randomized double-blind, placebo-controlled trial
that aims to determine the efficacy and safety of acupuncture intervention for neck pain caused by cervical
spondylosis. The primary outcomes are changes in the NPQ score and neck physiological function. Secondary
outcome measures include quality of life, adverse events, and relapse of neck pain. If successful, this project will
provide evidence of the efficacy and safety of acupuncture for neck pain caused by cervical spondylosis.
Trial registration: Chinese Clinical Trial Registry: ChiCTR-TRC-12002206.
Registration date: 11 May 2012.
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Cervical spondylosis (CS) is defined as age-related chro-
nic disc degeneration. It is also defined as vertebral
osteophytosis secondary to degenerative disc disease,
which in the cervical spine may be asymptomatic or can
present as pure axial neck pain, cervical radiculopathy,
cervical myelopathy, or cervical myeloradiculopathy [1,2].
Neck pain caused by CS (CS neck pain) is associated with
slight degenerative changes within the intervertebral
disc in early CS [3]. CS is usually asymptomatic, but may
present with symptoms of neck pain, neck stiffness, or
even shoulder pain and stiffness. Its etiological factors are
multifactorial and involve poor posture, anxiety, depres-
sion, neck strain, and sporting or occupational activities
[4]. With acceleration of the pace of modern life, com-
puters, air conditioning, fans, and cars have become
widely used, and CS neck pain has become a common
health problem worldwide. It is reportedly associated with
a 50% incidence of radiological evidence in individuals
over the age of 40 years and an 85% incidence of radio-
logical evidence in individuals over the age of 60 years [5].
Neck pain is one of the most frequent issues among pa-
tients with CS. About two-thirds of adults in the UK re-
portedly experience neck pain at some time in their lives,
with men more commonly affected than women, at a ratio
of 3:2 [6]. A Norwegian survey of 10,000 adults showed
that 34% of respondents had experienced neck pain in the
previous year [7]. In Hong Kong, the prevalence of neck
pain caused by CS is 15% to 17%, and the lifetime preva-
lence is 30% to 50% [8]. Approximately 33% of adults in
Canada and 43% in Sweden had experienced neck pain in
the past several months [9,10].
Non-surgical treatment is usually the most appropriate
course of initial management. Most CS neck pain res-
ponds to conservative measures. Stress management or
postural advice in daily activities, work, and hobbies is
effective for some patients with slight neck pain. The
current clinical treatments mainly include administra-
tion of non-steroidal anti-inflammatory drugs, muscle
relaxants, physiotherapy, analgesics, and so on [11].
However, there is little evidence to support the efficacy
of these therapies for CS neck pain. The most optimal
treatment has not yet been established.
Traditional Chinese medicine measures, such as acu-
puncture, massage, neck exercises and so on have been ex-
tensively used for the management of CS neck pain in
China and other countries; among these, acupuncture is
one of the most popular measures. A number of clinical
studies have been conducted to evaluate its efficacy
[12-16]. Their results suggested that acupuncture is effec-
tive for pain relief in the immediate and short-term post-
treatment period; however, the efficacy of a mid-term to
long-term benefit for pain control or functional improve-
ment was less clear [17-19]. Furthermore, comparativetrials in the literature are few in number and of poor qua-
lity. Therefore, we will conduct a rigorous evaluation to
test whether acupuncture performs better than placebo
for treatment of CS neck pain.
The overall goal of this project is to determine the




This study will be a randomized, double-blind, parallel
controlled clinical trial to evaluate the effectiveness and
safety of acupuncture for CS neck pain. A total of 458 sub-
jects with CS neck pain from outpatient clinics will be
recruited and randomly allocated to either the active acu-
puncture group (experimental group) or the sham acu-
puncture group (control group). The Second People’s
Hospital of Fujuan and the Affiliated Rehabilitation
Hospital, Fujian University of Chinese Medicine will be
responsible for recruiting, screening, and intervention of
all patients and assessment of all outcomes. Management
of the randomization sequence, blinding, and data ana-
lyses will be carried out by the Center for Evidence
Based Medicine of Fujian Traditional Chinese Medicine
University. Ethics approval has been received from Fujian
Traditional Chinese Medicine University. Informed writ-
ten consent will be obtained from all participants.
Participants
We will include patients between 18 and 60 years of age
with CS neck pain. Patients must have typical symptoms
of neck pain and stiffness, but their cervical vertebrae
must be normal or show only physiological curvature
changes on radiographic examination. Potentially eligible
participants are being identified through screening of
patient medical records at the participating hospitals.
Screening of patients will be performed by one of the au-
thors according to the inclusion and exclusion criteria. A
flow diagram of the patients is shown in Figure 1.
Inclusion criteria
To be eligible, participants must fulfill the following
criteria: (1) a confirmed diagnosis of CS neck pain in ac-
cordance with the diagnostic criteria published by the
Chinese Association of Rehabilitation Medicine (2010)
[20] and with reference to the International Classification
of Diseases, 10th edition (ICD-10) codes (http://www.
icd10data.com): M47.812 (other spondylosis without
myelopathy or radiculopathy (cervical region)); (2) male or
female 18 to 60 years of age; (3) with/without positive
signs of musculoskeletal system upon physical exami-
nation; (4) pain intensity ranging from 3 to 7 points on a
visual analog scale (VAS) upon recruitment; (5) no
Potential eligible outpatients 
Exclusion (reasons): n=
Not meeting inclusion criteria n=
Declined to participate n=
Other reasons n=Eligible patients n=456
Follow up for 12 weeks
Lost to follow up: n=
Intervention group: n=
Control group:  n=
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Figure 1 Flow diagram of participants.
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days; and (6) informed consent document has been
signed.Exclusion criteria
The exclusion criteria were as follows: (1) history of neck
trauma or T1 to T6 thoracic vertebra trauma; (2) has ver-
tebral body or spinal canal cancer, tuberculosis, or severe
osteoporosis; (3) history of neck surgery or presence of
congenital malformation of the cervical vertebrae; (4)
pregnant or lactating (women) or presence of a mental
disorder; (5) has a severe systemic disease such as
cardiocerebrovascular disease, tumors, diabetes mellitus,
kidney disease, or digestive system disease; (6) inability to
complete research questionnaires; and (7) rejection of
randomization.Sample size
The sample size calculation was based on a reference of
a similar intervention in similar patient groups using
the same primary outcome instrument [21]. The pri-
mary outcome measure is improvement of scores in
neck pain as measured with the Northwick Park Neck
Pain Questionnaire (NPQ) at the end of treatments.
According to previous research [21], the mean and standard
deviation of NPQ scores were (24.04 ± 11.83) in the pla-
cebo group and (20.71 ± 11.91) in the acupuncture group.
The sample size was calculated based on the formula:





with a type I error of 5% (α = 0.05) and 80% power (β =
0.2). A total of 198 patients are required in each group to
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mated that 15% patients will drop out of the study; thus,
456 patients was established as the sample size.
Randomization and allocation
The randomization schedule will be prepared by
the Evidence-Based Medicine Center of the Academy of
Integrative Medicine, Fujian University of Traditional
Chinese Medicine. The specific randomization lists will be
computer-generated using the SAS 8.12 software PLAY
PLAN program (SAS software (Beijing) Co., Ltd, No. 1
Changan Road, Dongcheng District, Beijing , China) and
concealed from the screeners, assessors, and patients by a
designer from the Evidence-Based Medicine Center who is
not involved in the study. Cards with group assignments
and detailed treatment schedules will be prepared by the
Evidence-Based Medicine Center and sealed in opaque en-
velopes. These sealed envelopes will be marked with the
patients’ sequential numbers and kept by the screeners
who are responsible for the screening of participants.
When a patient has been enrolled, written informed con-
sent has been obtained, and the patient has completed the
baseline measurements and is confirmed to be an eligible
participant, the envelope corresponding to the sequential
number of the patient will be transmitted to the acupunc-
turist. The acupuncturist will open the envelope and per-
form the intervention (active or sham acupuncture)
according to the treatment schedule written on the card.
The information of the allocation list will remain confi-
dential and kept by the acupuncturist not involved in par-
ticipant recruitment or outcome assessment, and this
information will not be shared with the data analyzers or
outcome assessors.
Blinding
The outcome assessors will be blinded to the rando-
mization allocation and will not be involved in perform-
ance of the interventions. Participants will be blinded to
the group allocation and will not know whether they have
been treated with active or sham acupuncture. It will be
impossible to blind the acupuncturists because they will
perform the interventional protocols. However, the acu-
puncturists will not take part in the outcome measure-
ments or the statistical analyses, and will be requested not
to disclose details about their treatment to the outcome
assessors or participants. The statistician will be blinded to
the group allocation until completion of the statistical
analyses.
Interventions
The intervention scheme originates from the guidelines
of diagnosis, treatment, and rehabilitation for CS [20]
and has been practiced for some time in the Second
People’s Hospital of Fujian Province and the AffiliatedRehabilitation Hospital, Fujian University of Chinese
Medicine. We hypothesized that acupuncture for CS neck
pain would have a more positive effect in terms of relie-
ving neck pain and recovering neck physiological function
than placebo (sham acupuncture). Therefore, participants
in the experimental group will receive the active acupunc-
ture treatment, and participants in the control group will
receive the sham acupuncture treatment. All participants
will receive 25 mg of diclofenac sodium three times a day
if their VAS scores exceed 5.
Active acupuncture
Active acupuncture treatment will be applied to the partic-
ipants in the experimental group. Active acupuncture
stimulation will be performed at the acupuncture points
Jing-jiaji (EX-B2.C5), Jing-jiaji (EX-B2.C6), Jing-jiaji (EX-
B2.C7), and Jianzhongshu (Sl15) on both sides of the body
[22]. Sterile single-use acupuncture needles (40 mm in
length and 0.30 mm in diameter; Hwato brand, Suzhou
Medical Products Factory Co., Ltd., 12–14 West Qilin
lane, Suzhou, China) will be perpendicularly inserted to a
depth of 20 to 30 mm at the selected stimulation point.
When the treated participants achieve de qi sensa-
tion (soreness, numbness, distention, and heaviness),
electroacupuncture with its anode connected to Jing-jiaji
(EX-B2.C5) and cathode connected to Jing-jiaji (EX-B2.
C7) will be performed to stimulate the relevant acupunc-
ture points for 20 minutes by a single experienced acu-
puncturist using a continuous-wave, 1-Hz frequency and a
comfortable strength.
Sham acupuncture
Sham acupuncture treatment will be applied to the par-
ticipants in the control group. The operation of sham
acupuncture will be same as that of active acupuncture
with the exception of the sites and depth used. Sham
acupuncture stimulation will be performed at sites 1.5
cm away from Jing-jiaji (EX-B2.C5), Jing-jiaji (EX-B2.
C6), Jing-jiaji (EX-B2.C7), and Jianzhongshu (Sl15), and
the depth of the inserted needles will be controlled
within 15 mm. The operation of electroacupuncture in
the control group will be same as that in the experimen-
tal group.
Intervention regimen
Patients will be required undergo ten treatment sessions
at a frequency of five sessions a week, and the intervention
will be completed in 2 weeks. All electroacupuncture pro-
cedures will be performed with a Hwato brand SDZ-II
electronic needle therapy instrument made by Suzhou
Medical Products Factory Co., Ltd. The two groups will be
separated from the treatment, which will be performed by
a single acupuncturist.
Que et al. Trials 2013, 14:186 Page 5 of 7
http://www.trialsjournal.com/content/14/1/186Follow-up period
During the 12-week unsupervised follow-up period, no
participants will undergo special therapy with the excep-
tion of routine cervical care. At post-treatment weeks 4,
8, and 12, the outcome assessor will telephone partici-
pants to investigate the recurrence of neck pain.
Outcome measurement
The following baseline descriptive data will be obtained
by questionnaire and physical examination: age, sex,
marital status, education level, employment status, fa-
mily history of CS, VAS score of cervical pain, function
of cervical vertebrae, and previous health problems. The
radiographic severity of cervical vertebral changes will
be assessed on X-ray images. A summary of all measures
in the trial is shown in Table 1.
Primary outcome measures
The primary outcomes are changes in the symptoms of
CS and function of the cervical vertebrae. Symptoms of
CS will be measured using the NPQ [22]. Function of the
cervical vertebrae, mainly including the activity of the cer-
vical vertebrae upon forward bending, lateral bending, and
rotation, will be measured using physical examination and
assessed by the outcome assessors.
Secondary outcome measures
Quality of life will be assessed using the Short Form-36
(SF-36) Questionnaire [23]. Neck pain will be assessed
using the McGill Pain Questionnaire [24]. The recovery
period is defined as the number of days from theTable 1 Study assessments, procedures, and timetable
Items Before grouping First
perio





Baseline information log X
Physical examination X
Visual analog scale score X
Randomization allocation X
Neck physiological function examination X
Intervention and record X
Adverse events record X
McGill pain score
Northwick Park Neck Pain Questionnaire score X
Short-Form 36 measure X
Neck pain relapsebeginning of treatment to recovery of cervical physio-
logical function and will be recorded by the outcome as-
sessors. Relapse of neck pain will be recorded by
telephone investigation during the follow-up period.Safety evaluation
Any adverse events (defined as any functional lesion
caused by the interventions, such as local bleeding at the
needle insertion point; local numbness, pain, or dizziness
during treatment and so on) will be recorded during
treatment. If any adverse event occurs, the doctor will
provide the corresponding treatment to the patient. The
adverse events will be immediately reported to the pri-
mary investigator and ethics committee to decide if the
patient needs to withdraw from the trial.Data collection and management
The demographic and baseline characteristic data will be
collected by screeners when the patients are recruited.
Clinical outcome measurement and questionnaire-based
assessment of treatment effects and neck physiological
function will be measured by the outcome assessors after
the treatment is completed. During the follow-up period,
relapse of neck pain will be investigated by a telephone
call at 4, 8, and 12 weeks post treatment.
Research assistants will conduct quality control of data
collection and be responsible for data entry. The data
manager will be responsible for initial data cleaning,
identifying, coding, and conversion into the proper for-












X X X X
Que et al. Trials 2013, 14:186 Page 6 of 7
http://www.trialsjournal.com/content/14/1/186Statistical analysis
The primary outcomes will undergo intent-to-treat ana-
lysis based on the initial treatment assignment and focus
on assessment of the main effects of the acupuncture
treatment for CS at symptoms of CS and function of the
cervical vertebrae. Analyses will be performed using IBM
SPSS 20 (version 20.0, IBM Corp., New York, NY, USA).
The continuous variables and descriptive values will be
expressed using means with standard deviations or me-
dians with ranges. For the variables with a normal distri-
bution, statistical comparisons between the groups
will be made by using a t test. If the variables have a
non-normal distribution or ordinal level, statistical
comparison between groups will be made using the
Mann–Whitney U test. Measures with a discrete distri-
bution will be expressed as percentages and analyzed by
the χ2 or Fisher’s exact test as appropriate. The amount
of extra diclofenac sodium used between the experi-
ment and control groups will be analyzed, and a general
linear model will be applied to adjust its confounding
influence if necessary.
Discussion
In this randomized, double-blind controlled trial of pa-
tients with CS neck pain, we intend to investigate the
mid-term efficacy and safety of acupuncture for CS neck
pain. This is a well designed study in strict accordance
with the Consolidated Standards of Reporting Trials
(CONSORT) statement of randomized controlled trials
and will enable determination of the effects of acupunc-
ture [25]. First, we estimated the most optimal sample size
to ensure adequate test performance. Second, we ensured
that this study is truly a randomized controlled trial to
the greatest extent possible by full implementation of
randomization and blinding. In addition, to assess the effi-
cacy of acupuncture for CS neck pain, the placebo effect
should be avoided. At present, ‘sham acupuncture’ is con-
sidered to be the most commonly proposed placebo con-
trol. In this protocol, sham acupuncture is applied by
adapting the depth of needling at non-acupuncture points.
This technique has been widely used in clinical trials,
many of which have adopted this method as a control
[26-30]. Its main advantages are that it is the strongest
type of patient blinding and is easy to carry out. Its main
problem is that the control group may play a role in the
treatment of the disease; thus, the effect of acupuncture
maybe be underestimated [31]. However, if the experimen-
tal results prove that acupuncture is indeed better than
the control group treatment, the efficacy of acupuncture
for CS neck pain will be positive. In terms of evaluation
indicators, we will use a reasonable specification, design a
rigorous professional scale as the evaluation indicator of
the primary outcome, and avoid a subjectively developed
fuzzy classification evaluation, distorting data less andreducing bias. The interventions (active or sham acupunc-
ture) will be performed by a fixed chief physician, who has
more than 20 years of clinical experience. This will im-
prove the participants’ compliance and reduce the risk of
dropout.
In summary, we have combined a proper clinical trial
design and acupuncture features and finished a scientific
design. We will report the clinical trial results in accor-
dance with international norms for randomized controlled
trial reporting (CONSORT) [25] and acupuncture clinical
trial intervention reporting standards (Standards for
Reporting Interventions in Clinical Trials of Acupuncture
(STRICTA)) [32]. This study has also been pasted by the
Ethics Committee of Fujian University of Traditional
Chinese Medicine; consequently, the results of this study
will generate scientifically rigorous clinical evidence for
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